Home › Products › Oncology › Jastinib 5mg Tablet

Jastinib 5mg Tablet

Salt Composition: AXITINIB

₹1610.00₹3501.00

Inclusive of all taxes

Jastinib 5mg Tablet

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Jastinib 5mg Tablet is an anticancer medicine from the class of tyrosine kinase inhibitors, containing the active ingredient Axitinib. It is prescribed for the treatment of advanced kidney cancer, also called renal cell carcinoma, which develops in the cells of the kidney. Patients obtaining Jastinib 5mg should procure it from licensed pharmacies with a valid prescription to ensure safety and authenticity. The Jastinib dosage is determined by the treating oncologist based on the patient's condition, medical history, and tolerance level. Do not self-adjust the dose without medical guidance. When comparing Jastinib with Inlyta, both contain Axitinib as the active ingredient and are used for similar indications, though brand availability, cost, and patient response may vary. If required, doctors may recommend Jastinib substitutes depending on the patient's response or drug availability. The Jastinib composition works by blocking specific enzymes (tyrosine kinases) that promote cancer cell growth and spread. Patient experiences with Jastinib can provide insights into treatment, though effectiveness and side effects differ for each individual. The Jastinib tablet price varies depending on the manufacturer, location, and pharmacy. Patients are advised to compare prices from licensed suppliers before purchase. Jastinib for kidney cancer is an important treatment option for advanced renal cell carcinoma and must be taken under strict medical supervision.

Uses

Jastinib uses are Advanced kidney cancer

How it works

It belongs to the category of tyrosine kinase inhibitors, which interferes with the growth of blood vessels inside the cancer cellS. It also acts against a protein called receptor tyrosine kinases to interrupt cell signalling, ultimately stopping the growth and spread of cancer cells.

How to Use

Your doctor will decide the dose and duration of Jastinib 5mg Tablet based on the disease condition. Always take this medicine as prescribed by your doctor. The recommended starting oral dose of Jastinib 5mg Tablet is 5 mg twice daily. Take the tablet at the same time everyday, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Jastinib side effects are Serious Extreme tiredness and swelling Pressure or pain in the chest, arms, back, neck or jaw Breathlessness Numbness and weakness on one side of the body Difficulty speaking or communicating verbally Headache Vision changes or dizziness Serious bleeding problems like black tarry stools, bloody cough or bloody sputum Severe stomach pain High blood pressure Common Kidney problems Dehydration Hyper-active thyroid gland Sore throat Loss of appetite Joint pain Lack of energy Weight loss Constipation Mouth sores Skin itching, redness of skin and hair loss

References

  1. Pfizer, [Revised on 13th Jan 2020] [Accessed on 23rd March 2023], https://www.pfizer.ca/sites/default/files/202001/INLYTA_PM_Approved_03Jan2020_E_DC.pdf
  2. Pfizer Labs, Electronic Medicines Compendium(EMC), [Revised on Mar 2021] [Accessed on 23rd March 2023], https://www.medicines.org.uk/emc/files/pil.4325.pdf
  3. Pfizer, Fact sheet, [Revised on Sep 2012] [Accessed on 23rd March 2023], https://cdn.pfizer.com/pfizercom/news/esmo/renal_cell_carcinoma_fact_sheet.pdf
  4. Annex I summary of Product Characteristics - European Medicines Agency. Available at: https://www.ema.europa.eu/en/documents/product-information/inlyta-epar-product-information_en.pdf (Accessed on March 25, 2023).
  5. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.

Safety Advice

Pregnancy: unsafe Jastinib 5mg Tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.

Lungs: Consult your doctor It is not known whether Jastinib 5mg Tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe It is unsafe to breastfeed during the treatment with Jastinib 5mg Tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS